cell_type,metadata_type,color,notes,cohort.cohortGuid,sample.sampleKitGuid,subject.biologicalSex,subject.birthYear,subject.ageAtFirstDraw,subject.ageGroup,subject.race,subject.ethnicity,sample.visitName,sample.visitDetails,sample.drawYear,sample.subjectAgeAtDraw,sample.daysSinceFirstVisit,sample.diseaseStatesRecordedAtVisit,am.bmi,am.height,am.weight,chem.alt,chem.albumin,chem.alkaline_phosphatase,chem.ast,chem.t_bili,chem.bun,chem.calcium,chem.co2,chem.cl,chem.creatinine,chem.egfr_aa,chem.egfr_non_aa,chem.globin,chem.glucose,chem.ldh,chem.magnesium,chem.phosphate,chem.potassium,chem.protein,chem.sodium,bc.perc_basophils,bc.perc_eosinophils,bc.perc_lymphocytes,bc.perc_monocytes,bc.perc_neutrophils,bc.basophil_count,bc.eosinophil_count,bc.lymphocyte_count,bc.monocyte_count,bc.neutrophil_count,bc.hematocrit,bc.hemoglobin,bc.mch,bc.mchc,bc.mcv,bc.mpv,bc.platelet_count,bc.red_blood_cell_count,bc.rdw,bc.wbc,cmv.igg_serology,cmv.igg_serology_interpretation,infl.anti_ccp3,infl.anti_ccp31,infl.hs_crp,infl.rf_iga_interpretation,infl.rf_iga_result,infl.rf_igm_interpretation,infl.rf_igm_result,infl.esr,lip.cholesterol_hdl,lip.cholesterol_ldl,lip.cholesterol_non_hdl,lip.cholesterol_total,lip.chlesterol_hdl_ratio,lip.triglycerides
BR1001,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00001,Female,1987,32,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,32,0,,23,177.4,71.1,8,4.7,47,16,0.5,11,9.5,22,106,0.93,94,81,2.6,33,,,,3.9,7,143,0.5,1.6,31.1,7.7,59.1,22,69,1337,331,2541,33.6,11,26.7,32.4,82.2,12.8,226,4,15.1,4.3,,,2,4,0.3,Negative,0,Negative,5.902,2,65,85,104,169,2.6,94
BR1002,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00002,Male,1991,28,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,28,0,,22,180.3,72.6,16,4.5,35,19,0.4,19,9.2,25,101,0.94,127,110,2.3,54,,,,3.3,7,140,0.9,2.4,39.5,8.9,48.3,50,132,2173,490,2657,42.4,14,31.5,34,92.8,10.2,224,5,11.9,5.5,,,,,0.3,,,,,2,56,72,99,155,2.8,197
BR1003,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00003,Female,1989,30,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,30,0,,21,175.3,64.4,11,4.5,45,16,1.7,10,9.2,26,103,0.67,137,118,2.8,47,,,,3.9,7,144,0.7,0.7,45.4,12.1,41.1,29,29,1861,496,1685,37.6,13,30,34,88.3,11.8,203,4,12.1,4.1,,,,,1.9,,,,,2,76,112,126,202,2.7,57
BR1004,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00004,Male,1989,30,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,30,0,,22,180.3,69.9,15,4.2,45,18,0.5,11,8.9,23,106,0.88,134,115,2.7,78,,,,3.9,7,141,1.1,2.5,49.8,10.9,35.7,32,73,1444,316,1035,37.3,13,30.8,33.8,91.2,9.8,216,4,12.2,2.9,,,,,0.3,,,,,2,60,63,76,136,2.3,47
BR1005,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00006,Female,1992,27,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,27,0,,20,170,59.2,12,4.5,35,13,0.3,8,9.2,26,102,0.63,142,123,2.4,44,,,,3.7,7,140,0.7,0.1,19,11.3,68.9,52,7,1406,836,5099,39.2,13,30.3,33.4,90.5,10,254,4,12,7.4,,,,,0.5,,,,,2,50,79,102,152,3,130
BR1006,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00010,Male,1988,31,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,31,0,,28,176,87.5,11,4.7,58,14,0.5,14,9.4,29,102,0.99,117,101,2,98,,,,4.2,7,138,0.8,1.5,35.3,11.8,50.6,32,60,1412,472,2024,40.6,14,31.9,34.7,91.9,11,198,4,12.4,4,,,,,1.7,,,,,2,56,65,77,133,2.4,50
BR1008,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00012,Female,1985,34,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,34,0,,34,157.5,83.6,26,4.5,68,23,0.6,8,9.5,30,101,0.62,136,118,2.8,99,,,,3.8,7,138,0.6,1.6,27.4,4.4,66,43,114,1945,312,4686,38.3,13,29.8,35,85.1,11.3,292,5,11.7,7.1,,,,,8.8,,,,,9,58,123,140,198,3.4,78
BR1007,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00014,Male,1989,30,Young Adult,Other,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,30,0,,21,178,67.1,9,4.8,32,14,0.4,12,9.4,28,102,1,117,101,2.6,86,,,,4.1,7,137,0.7,0.9,29.9,7.2,61.3,32,41,1375,331,2820,41.3,14,31.4,33.4,94.1,9.5,346,4,12.1,4.6,,,6,8,0.8,Negative,0,Negative,0,2,63,87,101,164,2.6,57
BR2003,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00015,Male,1960,59,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,59,0,,26,174,80.1,21,4.5,54,23,0.4,20,9.7,23,103,0.79,114,98,2.7,87,,,,4.4,7,140,0.3,2.1,27.7,8.2,61.7,22,151,1994,590,4442,43.7,15,31.3,34.3,91.2,10.7,192,5,12.8,7.2,,,,,0.5,,,,,9,81,161,179,260,3.2,80
BR2002,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00016,Female,1962,57,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,57,0,,22,160,57,16,4.5,68,17,0.8,15,10.4,24,107,0.87,86,74,2.1,99,,,,5.3,7,147,1.5,0.3,42.7,6.9,48.6,59,12,1665,269,1895,40.7,13,30.2,32.9,91.9,9.7,276,4,12.3,3.9,,,,,0.3,,,,,2,76,159,174,250,3.3,54
BR1010,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00022,Female,1990,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,29,0,,21,167.6,58.1,11,4.4,34,14,0.5,11,9.2,29,103,0.9,100,86,2.5,81,,,,4.6,7,140,0.3,2.8,33.8,9.6,53.5,12,112,1352,384,2140,40,13,32.5,33.5,97.1,12,199,4,11.7,4,,,,,7.4,,,,,2,85,70,90,175,2.1,114
BR1009,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00023,Female,1993,26,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,26,0,,23,162.3,61.7,11,4.6,51,19,0.5,10,9.7,26,106,0.71,136,118,2.8,84,,,,4.1,7,139,0.7,2.2,36.8,11,49.3,29,90,1509,451,2021,38.3,13,32.4,33.9,95.5,12.3,274,4,11.8,4.1,,,1,3,0.5,Negative,0,Negative,0,2,68,87,102,170,2.5,60
BR1011,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00025,Male,1988,31,Young Adult,African American,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,31,0,,25,175.26,77.1,25,4.2,44,24,0.4,13,9.2,26,103,0.91,130,112,2.5,102,,,,4.2,7,137,0.6,3.9,41.8,11,42.7,20,133,1421,374,1452,40.1,13,27.7,33.4,83,11.4,227,5,13.5,3.4,,,,,0.6,,,,,2,54,93,108,162,3,66
BR1012,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00026,Male,1988,31,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,31,0,,23,182,75,22,4.5,47,19,0.5,21,9.6,24,107,1.01,114,99,2.1,78,,,,4.5,7,141,0.2,1.4,26.4,9,63,13,91,1716,585,4095,41.4,14,26.5,32.6,81.3,11.4,226,5,12.7,6.5,,,,,0.5,,,,,2,47,110,132,179,3.8,117
BR1013,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00030,Female,1988,31,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,31,0,,23,148.59,51.3,13,4.3,38,16,0.5,10,9,23,105,0.47,153,132,2.9,118,,,,4,7,136,0.4,0.7,15.6,5.8,77.5,46,81,1794,667,8913,37.1,13,30.7,33.7,91.2,11.5,244,4,12.1,11.5,,,,,8.1,,,,,6,62,79,104,166,2.7,145
BR1014,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00031,Female,1993,26,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2019,26,0,,28,161.6,73.1,13,4.2,37,13,0.7,12,9.4,31,103,0.87,107,92,2.7,74,,,,4,7,140,0.8,4.4,24.8,6.1,63.9,51,282,1587,390,4090,40.7,14,30,33.4,89.8,11.2,240,5,12.4,6.4,,,,,1.8,,,,,2,69,148,165,234,3.4,73
BR1018,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00041,Male,1989,31,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,31,0,,31,184.5,104.2,19,4.7,57,18,0.5,16,9.8,27,105,0.94,126,108,2.6,131,,,,4.3,7,141,1.1,2.6,19.1,12.6,64.6,52,122,898,592,3036,45.2,16,31.1,36.3,85.6,10.4,254,5,12.6,4.7,,,,,1.9,,,,,2,35,128,167,202,5.8,241
BR1033,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00166,Female,1986,34,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,34,0,,22,181,73.1,11,4.2,25,14,0.7,15,9.2,25,106,1.14,73,63,2.5,73,,,,4,7,140,0.8,4,36.1,8.4,50.7,38,188,1697,395,2383,37.6,13,30.4,33.5,90.6,10.7,198,4,12.5,4.7,,,0,4,0.3,Negative,0,Positive,6.62,2,69,116,130,199,2.9,46
BR2009,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00334,Female,1961,59,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,59,217,,,,73.9,10,4.1,68,17,0.5,26,9.2,25,107,0.96,75,65,2.6,84,,,,4.3,7,139,0.7,1.6,35.7,9,53,31,70,1571,396,2332,39.7,13,31.3,33.2,94.1,10.2,248,4,12.1,4.4,,,0,5,0.3,Negative,0,Positive,16.503,2,74,143,157,231,3.1,47
BR1021,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00338,Female,1986,34,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,34,237,,,,67.1,22,4.4,68,24,0.7,17,9.3,27,104,0.99,87,75,2.5,82,,,,4,7,138,0.8,1.6,48.8,11,37.8,30,59,1806,407,1399,39.5,13,28.2,32.7,86.4,10.7,273,5,14,3.7,,,,,0.4,,,,,2,65,112,128,193,3,70
BR2038,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00339,Male,1965,55,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,0,,27,169.9,78.6,20,4.5,44,19,0.5,12,9.9,24,102,0.92,108,93,2.9,103,,,,4.2,7,142,0.6,5.2,37.3,9.4,47.5,29,250,1790,451,2280,42.8,14,27.6,33.4,82.6,11.1,195,5,13.5,4.8,,,,,0.7,,,,,2,60,116,131,191,3.2,59
BR1037,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00341,Female,1984,36,Young Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,36,181,,33,150.9,75.7,11,4.1,82,13,0.3,18,9.2,18,105,0.73,123,106,3.2,108,,,,3.9,7,138,0.6,3.9,18.7,6.6,70.2,53,343,1646,581,6178,40.2,13,28.2,32.6,86.5,9.5,327,5,13,8.8,,,0,4,0.7,Negative,0,Negative,0,9,44,87,115,159,3.6,184
BR2025,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00342,Male,1965,55,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,0,,29,166,80.5,22,4.8,53,22,0.5,19,10,23,109,0.91,110,95,2.7,99,,,,4.7,8,146,1,1.8,25.9,10.1,61.2,51,92,1321,515,3121,44.8,15,31.5,34.2,92.4,11.3,246,5,12.6,5.1,,,,,0.4,,,,,2,65,137,156,221,3.4,86
BR1031,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00345,Female,1987,33,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,33,201,,,,101.5,19,4.5,67,11,0.3,18,9,23,106,0.76,119,103,2.5,99,,,,4.3,7,138,0.5,2.5,24,6.6,66.4,51,253,2424,667,6706,43,15,30.6,34.2,89.4,10.1,266,5,13,10.1,,,0,3,4.1,Negative,0,Negative,0,2,41,106,124,165,4,86
BR1026,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00347,Female,1992,28,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,28,237,,,,63.1,22,4.5,48,42,0.7,12,9.7,25,107,0.77,122,105,2.8,71,,,,3.7,7,142,1.1,2.2,36.1,6.8,53.8,61,121,1986,374,2959,41.8,14,31.6,34,93.1,11.3,279,4,12.3,5.5,0.118,Negative,,,0.3,,,,,6,49,80,103,152,3.1,132
BR1025,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00349,Female,1985,35,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,35,238,,30,156,72.6,13,4.3,52,15,0.2,16,8.9,22,106,0.96,89,77,2.6,125,,,,4.5,7,141,0.9,6.6,27.2,7.8,57.5,50,370,1523,437,3220,39.7,13,32.4,33.5,96.6,10.4,244,4,11.3,5.6,,,,,3.6,,,,,2,56,73,91,147,2.6,94
BR1024,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00350,Female,1985,35,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,35,246,,20,166.9,55,7,4.3,33,15,0.5,17,9.4,23,105,0.64,134,116,3,82,,,,4.6,7,138,0.9,1.9,53.5,8.8,34.9,29,61,1712,282,1117,33.7,11,31.8,33.2,95.7,10.3,350,4,13.8,3.2,,,1,3,0.3,Negative,0,Negative,0,33,55,82,95,150,2.7,53
BR2010,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00352,Female,1959,61,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,61,215,,21,166.1,57,16,4.2,50,19,0.7,14,9.1,23,107,0.64,112,96,2.3,85,,,,4.2,7,139,0.5,2.8,19.4,8.1,69.2,30,168,1164,486,4152,41.2,14,31.3,34,92.2,10.7,193,4,12.1,6,,,,,4.3,,,,,2,96,129,143,239,2.5,57
BR2008,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00353,Female,1964,56,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,56,244,,22,163,58.4,16,4.3,70,15,1.3,10,9.5,26,102,0.68,113,98,2.1,109,,,,4.4,6,139,0.5,1.4,25,5,68.1,28,78,1400,280,3814,36.9,12,28,32.2,86.8,11.6,277,4,12.9,5.6,,,2,4,2.3,Negative,0,Negative,1.739,17,71,147,176,247,3.5,154
BR2013,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00356,Male,1961,59,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,59,199,,,,70.6,13,4.4,37,15,0.4,26,9.8,28,105,1.03,92,80,2.5,65,,,,3.8,7,140,1,3,31.6,8.9,55.5,40,120,1264,356,2220,38.9,13,31,33.7,92,12.1,186,4,12.8,4,,,,,0.4,,,,,6,62,85,99,161,2.6,64
BR1032,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00357,Male,1986,34,Young Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,34,220,,27,166.9,74.2,25,4.8,55,17,1.3,16,10.2,26,103,0.84,133,115,3,102,,,,4.5,8,140,0.7,4.9,41.1,6.2,47.1,48,338,2836,428,3250,48.8,16,27.6,32.4,85.3,9.6,330,6,12.3,6.9,,,0,2,0.3,Negative,0,Negative,0,2,44,112,147,191,4.3,233
BR1028,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00362,Female,1989,31,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,31,224,,,,65.9,11,3.7,43,14,0.3,17,9,20,105,0.77,119,103,2.5,94,,,,4.2,6,136,0.8,4.4,37.8,5.2,51.8,40,220,1890,260,2590,38.5,13,29,33.2,87.1,11.6,263,4,11.7,5,,,,,0.3,,,,,2,65,63,82,147,2.3,103
BR1040,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00363,Male,1991,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,29,0,,27,180,86.8,18,4.6,55,20,0.5,22,9.5,22,106,1.23,91,79,2.3,88,,,,4.3,7,140,0.5,1.9,39.7,9.9,48,21,80,1667,416,2016,42.4,14,26.5,32.1,82.7,11,221,5,12.9,4.2,,,,,0.3,,,,,2,45,89,108,153,3.4,94
BR1023,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00365,Female,1992,28,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,28,248,,,,68.6,12,4.8,74,14,0.9,12,9.5,25,106,0.79,,,2.3,90,,,,3.7,7,141,1,3.3,27.2,6.8,61.7,48,158,1306,326,2962,40.7,14,31.5,34.6,90.8,11.6,239,4,12.1,4.8,,,,,0.5,,,,,2,56,142,161,217,3.9,88
BR1019,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00366,Female,1985,35,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,35,215,,,,76.6,17,4.2,48,15,0.7,17,9.2,24,106,0.84,,,2.5,87,,,,3.8,7,138,0.6,1.1,26.6,6.5,65.2,39,72,1729,423,4238,38.1,13,31,33.9,91.6,11.5,232,4,11.8,6.5,,,1,4,3.1,Negative,0,Negative,0,2,58,173,197,255,4.4,110
BR2005,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00368,Female,1963,57,Older Adult,Caucasian,Hispanic or Latino origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,57,259,,28,157,69.8,28,4.3,94,23,0.4,13,9.8,20,108,0.85,,,2.8,76,,,,4.4,7,143,0.6,1.3,40.9,6.6,50.6,19,42,1309,211,1619,41.9,13,27.6,31.5,87.5,11.2,229,5,13,3.2,,,,,0.3,,,,,2,65,125,146,211,3.2,107
BR2037,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00369,Male,1963,57,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,57,0,,28,170.5,82.1,14,4.6,78,12,0.5,14,9,25,107,0.99,,,2.4,89,,,,3.8,7,141,0.2,4.7,34.8,6.7,53.6,9,212,1566,302,2412,41.6,14,30.1,32.9,91.4,10.7,187,5,12.7,4.5,,,,,0.8,,,,,2,62,139,159,221,3.6,102
BR2015,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00377,Female,1964,56,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,56,0,,34,169.9,97.8,38,4.2,70,24,0.3,11,9.9,23,101,0.58,,,2.5,90,,,,4.4,7,137,0.5,2,38,8,51.5,30,118,2242,472,3039,42.1,14,29.6,34.2,86.6,9.3,277,5,11.9,5.9,,,0,4,5.4,Negative,0,Negative,0,11,41,162,215,256,6.2,343
BR2039,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00383,Male,1965,55,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,0,,27,175.6,84.7,20,4.4,48,18,0.4,17,9.1,24,107,1.15,,,2.7,96,,,,4.4,7,141,0.7,4.5,28.9,7.2,58.7,39,248,1590,396,3229,42.2,14,31.4,34.1,91.9,12.5,154,5,13.1,5.5,,,,,0.3,,,,,2,75,129,145,220,2.9,66
BR1016,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00384,Male,1986,34,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,34,241,,31,176.5,96,77,4.6,40,40,0.9,15,9.6,23,103,0.92,,,2.7,121,,,,4.4,7,137,1.3,4.2,22.3,11.2,61,103,332,1762,885,4819,46.2,17,31,36.1,85.9,9.8,231,5,12.1,7.9,,,1,4,1.1,Negative,0,Negative,0,2,53,15,29,82,1.5,60
BR1043,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00386,Male,1985,35,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,35,0,,27,187,94.4,16,5.1,42,18,0.5,12,9.3,24,103,0.85,,,2.1,106,,,,3.7,7,140,0.6,2.7,31.3,7.7,57.7,29,130,1502,370,2770,43.2,15,29.2,33.8,86.4,11.6,145,5,12.6,4.8,,,,,1.2,,,,,2,39,55,70,109,2.8,66
BR2035,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00387,Female,1962,58,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,58,0,,22,162.2,57.8,10,4.2,78,14,0.4,10,9.4,22,107,0.89,,,2.4,72,,,,4.1,7,141,0.6,1.4,34.4,8,55.6,22,50,1238,288,2002,36.4,12,31.4,33.8,92.9,10.7,175,4,11.8,3.6,,,,,2.4,,,,,11,66,110,135,201,3,142
BR2016,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00388,Female,1958,62,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,62,0,,24,171,71.4,17,4.2,80,15,0.4,21,9.2,24,104,0.7,,,2.6,85,,,,4.1,7,140,0.9,1.5,25.8,9.4,62.4,41,69,1187,432,2870,41.4,13,28.9,32.4,89.2,12.9,203,5,12.8,4.6,,,,,1.6,,,,,6,52,130,156,208,4,148
BR2033,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00390,Male,1965,55,Older Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,0,,21,165.1,57.7,22,4.6,56,16,0.6,20,9.6,26,103,0.82,,,2.7,81,,,,4.6,7,142,1,2.4,31.5,7.7,57.4,57,137,1796,439,3272,48.9,16,30.2,32.9,91.7,10.1,263,5,11.8,5.7,,,3,5,0.3,Negative,0,Negative,2.086,2,47,110,139,186,4,173
BR1044,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00391,Male,1994,26,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,26,0,,,,,77,4.4,79,30,0.7,16,9.9,19,105,0.78,,,3.2,118,,,,4.1,8,139,0.6,3.4,43.8,5.8,46.4,51,289,3723,493,3944,44,15,31.1,34.5,90.2,10.6,245,5,12.8,8.5,,,,,3.8,,,,,11,29,117,146,175,6,173
BR2036,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00393,Female,1964,56,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,56,0,,23,162.2,61.2,15,4.3,60,19,0.4,20,9.3,20,105,1.08,,,2.2,91,,,,4.4,7,140,0.8,3.8,23.2,4.9,67.3,30,141,858,181,2490,38.6,13,30.4,33.4,90.8,11.7,181,4,12.9,3.7,,,0,3,0.5,Negative,0,Negative,0,2,77,148,165,242,3.1,71
BR2040,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00394,Female,1961,59,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,59,0,,37,165.1,100.4,10,4.1,39,12,0.4,14,9.1,26,103,0.86,,,2.4,114,,,,4.4,7,140,1.4,5.3,31.4,10,51.9,80,302,1790,570,2958,36.1,11,23.3,29.1,80.2,10.1,365,5,15.8,5.7,,,,,0.6,,,,,2,52,98,122,174,3.3,141
BR1042,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00398,Male,1989,31,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,31,0,,,,,33,4.8,58,19,1.2,12,10.2,22,106,0.86,,,2.4,110,,,,4.2,7,141,0.8,1.6,35.9,7.8,53.9,50,101,2262,491,3396,45,15,25.4,32.9,77.3,10.5,258,6,13.2,6.3,,,0,4,2.1,Negative,0,Negative,0,6,33,106,137,170,5.2,195
BR2034,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00501,Female,1957,63,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,63,0,,26,170.2,74.7,18,4.2,54,21,0.6,12,9.2,20,101,0.78,,,2.2,87,,,,3.9,6,137,1,2.1,28.3,9,59.6,29,61,821,261,1728,37.9,12,30.9,31.9,96.9,11.3,178,4,12.3,2.9,,,0,3,1,Negative,0,Negative,0,2,95,151,166,261,2.7,57
BR1045,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00504,Male,1991,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,29,0,,,,,19,4.7,77,15,1.8,12,9.5,23,105,0.82,,,2.5,112,,,,4,7,140,1.5,7.2,31.8,10.5,49,50,238,1049,347,1617,46.6,16,30,33.3,90.1,10.2,240,5,12.8,3.3,,,0,4,0.5,Negative,0,Negative,1.678,2,39,109,131,170,4.4,109
BR1017,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00507,Female,1990,30,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,30,258,,23,165,62,14,4.2,57,18,0.6,9,9.2,23,106,0.81,,,2.5,81,,,,4.3,7,140,0.7,2.4,32.2,6.4,58.3,39,132,1771,352,3207,41.6,14,29.1,32.5,89.7,11.7,216,5,12.9,5.5,,,,,0.5,,,,,2,83,115,128,211,2.5,52
BR2022,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00510,Male,1965,55,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,71,,29,175,88,17,4.2,44,14,0.4,17,9.1,22,106,1.01,,,2.2,116,,,,4.1,6,140,0.9,7.4,26.5,6.9,58.3,52,429,1537,400,3381,42.2,15,29.9,34.6,86.3,10.3,265,5,13.9,5.8,,,3,4,0.5,Negative,0,Negative,0,2,50,141,174,224,4.5,193
BR1015,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00514,Male,1987,33,Young Adult,Other,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,33,253,,,,,24,4.9,43,29,0.8,12,10.1,27,100,0.96,,,3,77,,,,3.5,8,140,0.5,0.4,33.1,7.6,58.4,38,30,2483,570,4380,46.3,16,31.2,35,89.2,11.1,311,5,12.1,7.5,,,1,3,0.3,Negative,0,Negative,0,6,102,130,144,246,2.4,50
BR2041,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00516,Female,1958,62,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,62,0,,28,158,69.8,13,4.3,54,17,0.5,14,9.5,25,106,0.77,,,2.3,85,,,,4.2,7,139,0.7,2,56.1,6.9,34.3,39,110,3086,380,1887,40.4,14,31,34.9,88.8,10.1,306,5,12.8,5.5,,,0,2,2.9,Negative,0,Negative,0,9,49,167,201,250,5.1,186
BR1049,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00518,Male,1985,35,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,35,0,,24,189.5,87,27,5,39,21,0.6,18,9.6,27,106,0.9,,,2.4,72,,,,3.8,7,142,0.5,4.1,26,7.9,61.5,28,230,1456,442,3444,40.9,14,28.8,33.5,85.9,8.9,303,5,13.9,5.6,,,2,5,0.4,Negative,0,Negative,0,2,44,161,181,225,5.1,94
BR2047,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00520,Male,1964,56,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,56,0,,29,185.4,101.3,35,4.6,83,26,0.5,24,9.6,22,105,0.99,,,3.1,82,,,,3.9,8,137,0.9,3.1,22.7,7.5,65.8,61,211,1544,510,4474,42.2,15,30,35.1,85.6,10.3,222,5,13,6.8,,,,,1,,,,,2,65,134,156,221,3.4,108
BR2048,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00523,Male,1963,57,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,57,0,,28,182,93.3,18,4.8,63,16,0.7,16,9.7,22,107,0.83,,81,2.2,96,,,,4,7,139,0.4,1.8,34.3,8.4,55.1,20,88,1681,412,2700,39.7,12,18.1,31.2,57.9,10.6,213,7,17.8,4.9,,,,,0.4,,,,,2,37,137,165,202,5.5,152
BR1030,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00525,Female,1991,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,29,258,,19,169.9,55.5,11,4.6,54,12,0.4,9,9.8,19,105,0.72,,,2.7,75,,,,4.1,7,137,0.5,1.7,23.5,6.8,67.5,47,158,2186,632,6278,40.2,13,28.2,32.6,86.5,10.4,281,5,11.7,9.3,,,2,2,0.3,Negative,0,Negative,4.752,2,64,101,118,182,2.8,81
BR2032,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00526,Female,1960,60,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,60,0,,25,161.5,66.4,15,4.5,71,15,0.4,16,9.8,21,109,0.72,,,2,100,,,,4.4,7,142,0.6,0.9,40.7,10.9,46.9,21,32,1425,382,1642,41.6,14,31.7,34.4,92.2,11.4,203,5,11.8,3.5,,,0,3,1.8,Negative,0,Negative,0,2,76,101,120,196,2.6,93
BR1050,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00529,Female,1989,31,Young Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,31,0,,26,160,66,14,4.4,49,17,0.6,12,9.3,21,106,0.89,,,2.8,88,,,,3.9,7,138,1.1,5.8,30.5,8,54.6,72,377,1983,520,3549,42.5,14,32,33.2,96.6,11.3,275,4,11.7,6.5,,,,,0.3,,,,,11,56,117,143,199,3.6,149
BR2012,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00530,Female,1965,55,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,0,,33,168,94.2,26,4.5,64,24,0.5,14,9.3,27,103,0.91,,,2.6,82,,,,4.1,7,139,1.3,5.6,32.1,7.6,53.4,82,353,2022,479,3364,42.7,15,30.4,34.2,89,9.8,342,5,13,6.3,,,0,3,0.8,Negative,0,Negative,0,6,51,178,223,274,5.4,250
BR1048,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00532,Female,1985,35,Young Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,35,0,,39,163.6,104.4,21,4.7,55,18,0.6,12,9.6,21,108,0.8,,,2.8,101,,,,4.2,8,140,0.8,4.8,24.9,6.3,63.2,49,293,1519,384,3855,37.7,13,32.6,35.5,91.7,10.2,349,4,11.8,6.1,,,,,0.6,,,,,34,41,212,245,286,7,166
BR2044,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00533,Female,1959,61,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,61,0,,29,161,75,16,4,82,17,0.3,19,9.3,28,107,0.68,,,2.6,85,,,,4.9,7,143,0.6,3.1,35.6,9.6,51.1,31,161,1851,499,2657,35,11,27.5,32.6,84.3,10,449,4,13.1,5.2,,,,,1.4,,,,,6,62,102,121,183,3,101
BR1047,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00535,Male,1988,32,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,32,0,,22,174,67.7,20,4.9,46,19,0.6,9,9.9,27,104,0.86,,,2.2,89,,,,4.5,7,140,0.8,3.8,46.5,9.5,39.4,42,201,2465,504,2088,42.8,15,32,34.6,92.4,10.3,245,5,12.3,5.3,,,,,0.3,,,,,2,67,131,151,218,3.3,92
BR2014,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00537,Female,1958,62,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,62,100,,,,57.8,13,4.1,57,15,0.6,16,9.3,24,107,0.76,,,2.6,118,,,,4.4,7,137,1.2,2.8,23.1,9.9,63,50,118,970,416,2646,35.3,12,31.6,34.8,90.7,10.6,261,4,12.5,4.2,,,0,3,0.3,Negative,0,Negative,0,2,108,116,130,238,2.2,51
BR2020,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00539,Male,1957,63,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,63,89,,,,,28,3.9,52,22,0.5,20,9.1,28,105,1.1,,,2.8,101,,,,4.3,7,139,0.5,2.9,22.3,10.1,64.2,33,191,1472,667,4237,43.6,15,30.4,34.2,89,10.9,298,5,12.7,6.6,,,0,6,7.4,Negative,1.39,Negative,5.057,9,44,115,145,189,4.3,186
BR2043,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00541,Female,1959,61,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,61,0,,28,154.2,65.6,42,4.4,93,22,0.5,14,9.2,29,103,0.84,,,2.7,89,,,,3.9,7,138,1,2.2,27.4,6.8,62.6,63,139,1726,428,3944,41.6,14,30.2,33.7,89.7,11.8,229,5,13.1,6.3,,,,,1.7,,,,,2,46,177,242,288,6.3,382
BR2042,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00545,Female,1965,55,Older Adult,Caucasian,Hispanic or Latino origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,55,0,,35,165.7,95.8,19,4.5,59,19,0.5,19,9.4,24,104,0.94,,,2.7,83,,,,4,7,141,0.6,1.9,21.5,8.7,67.3,38,120,1355,548,4240,44,15,28.7,33,87,10.2,294,5,14.2,6.3,,,,,1.8,,,,,2,46,58,77,123,2.7,104
BR1051,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00549,Male,1994,26,Young Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,26,0,,24,186.5,82.7,18,4.5,49,25,0.6,14,9.4,20,104,0.99,,,2.7,87,,,,3.7,7,140,0.6,2.1,44.7,8.3,44.3,43,149,3174,589,3145,43.9,15,31.1,33.3,93.4,10.8,223,5,12.3,7.1,2.331,Positive,,,0.4,,,,,2,66,105,124,190,2.9,95
BR2024,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00552,Female,1958,62,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,62,78,,30,162.3,80,11,3.8,79,10,0.4,18,9.2,18,107,0.73,,,2.5,114,,,,4.2,6,135,0.3,3.2,28.3,7.9,60.3,26,278,2462,687,5246,38.1,13,30.3,33.6,90.3,10.7,264,4,11.8,8.7,,,26,20,0.7,Negative,0,Negative,0,2,49,95,113,162,3.3,89
BR2045,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00557,Female,1964,56,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,56,0,,43,161.8,112.5,35,3.9,74,19,0.3,24,9,25,101,0.88,,,3.3,160,,,,3,7,140,0.3,2.3,26.3,4.5,66.6,26,198,2262,387,5728,41.1,14,27.7,33.6,82.4,11.2,257,5,14.1,8.6,2.717,Positive,6,6,10,Negative,0,Negative,0,22,56,80,96,152,2.7,81
BR2029,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00561,Female,1962,58,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,58,69,,24,161,62.7,16,4.5,54,19,0.5,15,9.2,25,106,0.82,,,2.4,90,,,,4.5,7,140,0.7,3.8,41.7,6.9,46.9,39,209,2294,380,2580,37.5,13,29.5,34.1,86.4,11.5,288,4,12.4,5.5,3.199,Positive,0,4,1,Negative,0,Negative,0,6,58,120,140,198,3.4,96
BR2023,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00562,Male,1959,61,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,61,79,,,,85.9,17,4.4,52,20,0.5,21,9.1,29,104,0.93,,,2.6,100,,,,4,7,141,0.6,3.3,27.1,7.2,61.8,31,172,1409,374,3214,44.3,15,30.8,34.8,88.6,10.6,192,5,12.2,5.2,0.125,Negative,,,0.3,,,,,2,43,115,129,172,4,62
BR2031,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00563,Male,1960,60,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,60,64,,21,175,64.7,21,4.5,48,25,0.7,13,9.4,29,105,0.94,,,2.4,99,,,,4.7,7,142,1.1,0.3,29.7,9,59.9,41,11,1099,333,2216,42.2,14,31.6,34.1,92.5,10.3,233,5,12,3.7,0.222,Negative,0,4,0.5,Negative,0,Negative,0,2,54,92,107,161,3,67
BR2046,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00564,Male,1955,65,Older Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,65,0,,28,173,85,24,4.1,80,17,0.5,18,8.8,27,106,1.42,,,2.4,93,,,,4,7,142,1.8,3.3,17.8,11.1,66,59,109,587,366,2178,39.7,14,31,34,91.3,10.1,212,4,13.3,3.3,0.057,Negative,,,1.2,,,,,2,38,128,160,198,5.2,186
BR1054,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00565,Male,1991,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,29,0,,27,171.1,77.7,19,4.8,43,21,0.6,9,9.4,27,105,0.81,,,2.4,124,,,,3.9,7,141,1.5,1.9,41.2,8.4,47,39,49,1071,218,1222,44.7,16,33.1,35.3,93.7,10.7,170,5,12.4,2.6,0.069,Negative,,,0.3,,,,,2,57,119,150,207,3.6,192
BR2026,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00566,Male,1960,60,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,60,79,,35,175,106.6,26,4.1,65,25,1.2,18,9.4,29,101,0.82,,,2.6,91,,,,4.2,7,138,0.4,1.7,32.4,5.9,59.6,19,82,1555,283,2861,39.8,13,31.3,33.7,93,11.8,191,4,11.7,4.8,0.042,Negative,,,1.5,,,,,6,32,79,96,128,4,91
BR2021,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00568,Female,1961,59,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,59,102,,27,174.6,83.5,15,4.2,64,14,0.4,14,9.4,26,105,0.76,,,2.7,86,,,,4,7,139,0.7,1.8,33.1,7.4,57,39,101,1854,414,3192,38.8,13,29.8,33,90.2,10.1,354,4,13,5.6,,,0,6,1.4,Negative,0.361,Positive,6.91,11,51,98,127,178,3.5,194
BR2018,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00569,Female,1957,63,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,63,105,,28,169.5,81.1,23,4.5,95,22,0.3,15,9.8,26,104,0.72,,,2.7,87,,,,3.9,7,139,0.7,1.5,32.8,8,57,41,89,1935,472,3363,40,13,26.2,32,82,10.2,308,5,13.1,5.9,,,0,3,3.9,Negative,0,Negative,1.896,19,78,149,165,243,3.1,69
BR1041,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00575,Female,1992,28,Young Adult,Asian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,28,0,,27,153,62.1,16,4.6,61,17,0.4,12,9.8,25,102,0.83,,,3.5,82,,,,4,8,138,0.8,5.6,26.7,6.8,60.1,50,353,1682,428,3786,41.8,14,31.1,34.4,90.3,10.3,344,5,11.8,6.3,,,1,3,2.5,Negative,0,Negative,0,14,71,172,188,259,3.6,69
BR2019,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00582,Male,1963,57,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,57,105,,26,175,80.6,18,4.1,48,25,0.4,17,9.5,26,105,0.79,,,3.2,92,,,,4.1,7,139,0.6,0.3,17.9,6,75.2,41,20,1217,408,5114,39.4,14,33.8,35.8,94.5,10.1,258,4,12.7,6.8,,,,,2.7,,,,,9,79,155,196,275,3.5,243
BR2028,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00588,Male,1958,62,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,62,72,,,,67.7,15,4.4,43,17,0.6,15,9.1,25,107,0.84,,,2.3,124,,,,4,7,139,1.2,1.2,20.8,9.5,67.3,59,59,1019,466,3298,40.8,14,30.3,33.6,90.3,10.5,299,5,13,4.9,,,13,16,0.5,Positive,12.027,Negative,0,2,86,114,131,217,2.5,77
BR1052,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00592,Male,1992,28,Young Adult,Caucasian,Hispanic or Latino origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,28,0,,,,,15,4.7,35,19,0.9,17,9.4,26,105,0.93,,,1.8,80,,,,3.9,7,140,0.9,4.7,36.5,9.3,48.6,51,268,2081,530,2770,41.2,15,31.4,35.9,87.5,10.5,198,5,12.1,5.7,,,1,4,0.3,Negative,0,Negative,0,14,47,66,78,125,2.7,50
BR2052,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00599,Female,1957,63,Older Adult,Other,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,63,0,,38,161,99.3,21,4.4,82,21,0.4,17,9.6,25,99,0.87,,,2.9,82,,,,3.4,7,136,0.4,3.3,31.8,10.5,54,19,158,1526,504,2592,40.7,14,30.4,33.7,90.2,9.6,375,5,13.6,4.8,,,,,3,,,,,9,65,139,182,247,3.8,280
BR2030,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00600,Male,1962,58,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,58,90,,,,84.1,13,4.3,57,13,0.5,21,9.4,27,107,0.99,,,2.1,108,,,,3.9,6,140,0.5,2.4,24.7,9.2,63.2,38,182,1877,699,4803,43.9,15,30.2,34.4,87.8,10.3,196,5,13.1,7.6,,,,,1.1,,,,,2,39,109,156,195,5,352
BR2051,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00602,Female,1961,59,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,59,0,,24,160.7,61.2,10,4.5,125,17,0.3,13,9.5,28,102,0.66,,,2.4,82,,,,4.1,7,137,0.5,1.5,26.1,8.8,63.1,33,99,1723,581,4165,41.1,14,30.7,33.6,91.3,10.9,294,5,12.3,6.6,,,2,3,0.6,Negative,0,Negative,0,11,51,121,146,197,3.9,142
BR1056,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00621,Female,1995,25,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,25,0,,29,170,82.7,9,4.5,53,13,0.6,7,9.4,23,106,0.75,,,3,70,,,,4.1,8,140,0.9,1.9,37.7,6.3,53.2,52,110,2187,365,3086,45.4,16,30.4,34.1,89,10.6,323,5,12.8,5.8,,,,,1.2,,,,,2,57,97,116,173,3,101
BR2050,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00623,Male,1960,60,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,60,0,,25,177,78.7,34,4.7,51,34,0.5,15,9.8,27,105,1.01,,,2.5,98,,,,4.1,7,137,0.2,0.7,20.5,6.7,71.9,12,41,1210,395,4242,38.7,13,33.8,34.1,99.2,10.3,230,4,11.9,5.9,,,0,3,2,Negative,0,Negative,0,6,86,77,93,179,2.1,84
BR2053,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR2,KT00625,Male,1956,64,Older Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,64,0,,31,178.1,97.3,18,4.6,104,14,0.4,15,9.5,26,104,0.92,,,2.2,121,,,,4,7,138,0.6,1.5,37,6,54.9,37,93,2294,372,3404,44.7,15,29.8,34,87.6,8.8,260,5,13.5,6.2,,,0,2,1.3,Negative,0,Negative,0,9,30,,180,210,7,506
BR1057,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT00645,Female,1995,25,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2020,25,0,,23,180,76,12,4.7,34,16,0.3,10,9.4,21,105,0.81,,,2.6,83,,,,3.9,7,140,0.6,0.5,33.5,5.2,60.2,38,32,2144,333,3853,37.4,13,30.7,33.7,91,11.5,250,4,12,6.4,,,2,2,1.8,Negative,0,Negative,0.458,6,53,105,134,187,3.5,176
BR1058,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT01425,Female,1992,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2021,29,0,,23,170,65.6,8,5,45,12,0.4,19,9.6,17,108,0.77,,,2.4,92,,,,3.8,7,142,0.5,0.5,38.4,9.5,51.1,19,19,1421,352,1891,37,13,31.6,34.1,92.7,10.2,205,4,12.2,3.7,,,,,0.3,,,,,2,82,94,107,189,2.3,45
BR1059,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,BR1,KT01446,Male,1992,29,Young Adult,Caucasian,Non-Hispanic origin,Flu Year 1 Day 0,N/A - Flu-Series Timepoint Only,2021,29,0,,29,178,93.1,32,5.1,68,21,0.5,12,9.6,30,100,0.97,,,2.6,82,,,,4.5,8,138,0.6,4.4,27.8,11.9,55.3,32,238,1501,643,2986,43.4,14,29.8,33.2,89.7,10.1,300,5,12.2,5.4,,,,,1,,,,,2,41,116,144,185,4.5,167
UP1008,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00809,Female,2009,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2020,11,0,,,,,24,4.6,363,26,0.5,12,9.7,24,102,0.52,,,,78,,,,3.8,7,138,0.5,2.6,47.7,5.7,43.5,0,100,2100,300,1900,35,12,30,35,85,,317,4,12.5,4.4,,,,,,,,,,,,,,,,
UP1011,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00811,Female,2009,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2020,11,0,,,,,11,4.5,340,23,0.3,13,9.2,26,105,0.53,,,,75,,,,4,7,141,0.8,3,51.6,5.8,38.8,0,100,2500,300,1900,38,13,30,35,88,,250,4,12.6,4.9,0.04,Negative,,,,,,,,,,,,,,
UP1012,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00193,Female,2009,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2020,11,0,,,,,13,4.8,180,24,0.4,9,9.5,25,104,0.58,,,,110,,,,3.7,7,140,0.2,0.7,51.7,7,40.4,0,0,2600,400,2100,39,13,28,35,81,,203,5,12.9,5.1,0.034,Negative,,,,,,,,,,,,,,
UP1014,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00841,Female,2009,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2020,11,0,,,,,18,4.9,308,21,0.3,13,10.2,27,101,0.49,,,,69,,,,3.9,8,140,0.5,1.6,39.6,5.8,52.5,0,100,3100,500,4100,40,14,28,34,80,,376,5,13.2,7.9,0.05,Negative,,,,,,,,,,,,,,
UP1015,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00842,Male,2009,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2020,11,0,,,,,12,4.3,248,21,0.4,13,9.3,26,106,0.62,,,,80,,,,4.3,6,141,0.7,5.8,55.5,9.3,28.7,0,200,2300,400,1200,39,14,30,35,84,,273,5,12.7,4.2,0.035,Negative,,,,,,,,,,,,,,
UP1017,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00833,Male,2009,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2020,11,0,,,,,16,4.7,207,24,0.3,16,9.5,26,104,0.53,,,,73,,,,4.2,7,141,0.4,3,41.1,8.4,47.1,0,200,2900,600,3400,38,13,29,35,83,,264,5,12.7,7.2,0.049,Negative,,,,,,,,,,,,,,
UP1018,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00910,Female,2010,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,11,0,,,,,11,4.5,216,25,0.8,11,9.6,26,100,0.45,,,,94,,,,4.1,7,135,0.9,3.8,61.1,5.3,28.9,0,200,3000,300,1400,37,12,30,34,90,,322,4,12.7,4.9,,,,,,,,,,,,,,,,
UP1021,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00884,Male,2010,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,11,0,,,,,13,4.5,222,20,0.2,17,9.5,25,104,0.49,,,,74,,,,4.2,7,142,0.9,2.5,35.1,9.5,52,100,200,2200,600,3200,12.2,35,28,35,82,,274,4,14,6.2,,,,,,,,,,,,,,,,
UP1022,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00892,Male,2010,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,11,0,,,,,5,4.9,183,22,0.3,13,9.2,27,104,0.47,,,,85,,,,4.1,7,141,0.7,0.8,35.4,7.1,56,100,100,2500,500,4000,37,13,30,34,88,,287,4,12.4,7.1,,,,,,,,,,,,,,,,
UP1023,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00914,Male,2010,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,11,0,,,,,24,4.5,252,31,0.5,14,9.3,25,103,0.45,,,,83,,,,4.5,7,139,1.2,2.1,38.3,8.6,49.8,100,100,2000,500,2600,40,14,29,35,83,,278,5,12.7,5.3,,,,,,,,,,,,,,,,
UP1024,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00913,Male,2009,12,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,12,0,,,,,16,4.3,238,28,0.4,16,9.1,25,105,0.53,,,,74,,,,4.1,7,139,0.7,2.5,35.5,9.3,52.2,100,200,2600,700,3900,36,13,30,36,84,,257,4,13.4,7.4,,,,,,,,,,,,,,,,
UP1025,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00927,Female,2010,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,11,0,,,,,18,4.9,262,21,0.4,14,9.7,25,104,0.54,,,,51,,,,3.5,7,142,0.4,0.9,39.2,7.5,52,0,100,2900,600,3900,38,13,28,34,82,,320,5,13.5,7.5,,,,,,,,,,,,,,,,
UP1026,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT00928,Male,2009,12,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,12,0,,,,,13,4.5,252,19,0.5,13,9.2,28,107,0.72,,,,64,,,,4.3,6,143,0.9,0.07,1.85,6.7,,30,1900,47600,260,1660,41,14,31,34,90,,209,5,13.5,3.9,,,,,,,,,,,,,,,,
UP1031,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT02391,Female,2010,11,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,11,0,,,,,12,4.6,212,25,0.4,18,9.6,28,102,0.7,,,,58,,,,3.9,7,139,1.1,6.5,49.9,7.8,34.7,100,400,2800,400,1900,40,14,30,35,88,,300,5,12.9,5.6,,,,,,,,,,,,,,,,
UP1032,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT02392,Female,2009,12,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2021,12,0,,,,,13,4.4,260,19,0.3,9,9.3,27,107,0.57,,,,89,,,,4,7,145,0.4,2.5,45.8,4.3,47,0,100,2000,200,2100,39,13,30,35,86,,275,4,13.8,4.4,,,,,,,,,,,,,,,,
UP1034,donor,,The remaining rows correspond to donor information from https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/downloads/clinical/,UP1,KT03223,Male,2010,12,Children,Caucasian,Non-Hispanic origin,Flu Year 1 Pre-Vac 7-12 Weeks,N/A - Flu-Series Timepoint Only,2022,12,0,,,,,11,4.3,193,21,0.3,11,8.8,27,102,0.48,,,,78,,,,3.9,7,137,0.4,3.6,54.6,8,33.2,0,200,2800,400,1700,37,13,27,34,79,,232,5,12.9,5.1,,,,,,,,,,,,,,,,
T cell,Level 1 cell type,#5480A3,"T cell: We distinguished T cells from other peripheral immune cell populations based on expression of T cell receptor (TCR) complex genes, includingTRACorTRDCas well as CD3 genes (CD3D,CD3E,CD3G). Of note, T cells are defined by high expression ofCD3D,CD3EandCD3G, whereas NK cells expressCD3Eat high levels but are distinguished from T cells by low to no expression ofCD3DandCD3G.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
B cell,Level 1 cell type,#A3787B,"B cell: We distinguished B cells, including plasma cells, from other peripheral immune cell populations based on expression of B cell receptor (BCR) complex genes. These include co-receptor genesCD19,CD79A,CD79BandCD21as well as immunoglobulin genes, including the heavy chain (IgH) constant genesIGHM,IGHD,IGHA1,IGHA2,IGHG1,IGHG2,IGHG3,IGHG4, andIGHEand light chain constant genesIGKC,IGLC2, orIGLC3.MS4A1, which encodes the CD20 surface receptor, andPAX5transcription factor gene expression have ubiquitous B cell expression, with Plasma cells as the exception. Furthermore, we confirmed positive expression of genes that enable antigen presentation, specifically class II major histocompatibility complex (MHC) loci such as HLA-DR and HLA-DQ. Plasma cells were expected to have slightly reduced class II MHC gene expression and significantly higher immunoglobulin gene expression levels.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NK cell,Level 1 cell type,#FF7F55,"NK cell: For use at the broadest level of our Immune Health Atlas, Level 1, these two classes are combined to define NK cell as a label encapsulating both classical subclasses.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Monocyte,Level 1 cell type,#B75228,"Monocyte: TheMonocyte class was identified based on high expression of the genes encoding ficolin 1 (FCN1) and cathepsin S (CTSS). Because these genes are also expressed in some dendritic cell (DC) types, we can distinguish monocytes from DCs by low expression of the cDC2 marker CD1c (CD1C).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DC,Level 1 cell type,#F8C755,"DC: Dendritic cells (DCs) were identified by high expression of the cystatin C (CST3) gene, which is shared with monocytes, and the CD135 gene, fms related receptor tyrosine kinase 3 (FLT3), which is also expressed by some progenitor cell types, but has much lower expression in monocytes. Most DCs also express high levels of the major histocompatibility complex, class II genesHLA-DPA1,HLA-DRA, andCD74.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ILC,Level 1 cell type,#F4AD3A,"ILC: We identify a population at all levels of our type hierarchy for ILCs. While further division of subpopulations of ILCs is possible (Spits and Cupedo, 2012), the low abundance of circulating ILCs available in our PBMC dataset prevented further segregation of subclasses.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Progenitor cell,Level 1 cell type,#A31001,"Progenitor cell: Progenitor cells are rare in peripheral blood, and this class encapsulates three diverse progenitor cell types found in blood, which are described in more detail at Level 3. Progenitor cells can be identified by expression of the small integral membrane protein 24 gene (SMIM24) or the CD34 molecule gene (CD34).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Platelet,Level 1 cell type,#5B3930,Platelet: Platelets are blood clotting components derived from the cytoplasm of megakaryocytes and lack a nucleus. They can be identified by high levels of the pro-platelet basic protein gene (PPBP) and the tubulin beta 1 class VI gene (TUBB1).,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Erythrocyte,Level 1 cell type,#1F1515,"Erythrocyte: Erythrocytes, often referred to as red blood cells, are cells that carry hemoglobin throughout the body. These cells can be identified by expression of the hemoglobin alpha 1 and 2 gene or the hemoglobin beta gene (HBA1,HBA2, andHBB, respectively). Erythrocytes also lack a nucleus, so have fewer detected genes per cell than most other cell types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Naive CD4 T cell.L2,Level 2 cell type,#597FC6,"Naive CD4 T cell: Naive CD4 T cells are an antigen-inexperienced CD4 T cell population. This population is defined by expression ofCD27,CCR7,SELL,TCF7andLEF1, and the lack ofITGB1, an integrin specifically expressed on memory T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Memory CD4 T cell.L2,Level 2 cell type,#233C5B,"Memory CD4 T cell: Memory CD4 T cells arise when Naive CD4 T cells encounter their cognate antigen and receive further activating signals, which support differentiation. This population isdelineated in scRNA-seq by the expression ofITGB1.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Treg.L2,Level 2 cell type,#001A9A,"Treg: Regulatory T cells (Tregs) are a population of T cells that help tune down or suppress immune responses. This population isdefined by the expression ofFOXP3,IL2RA,IKZF2andRTKN2.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DN T cell.L2,Level 2 cell type,#656E68,"DN T cell: Double-negative (DN) T cells are defined as alpha-beta T cell populations (expressingTRAC) that lack the expression ofCD4,CD8AandCD8B.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Proliferating T cell.L2,Level 2 cell type,#AEAEB0,"Proliferating T cell: Proliferating T cells are defined as alpha-beta or gamma-delta T cell populations that express genes indicative of cell cycling, includingMKI67. This is a mixed population of T cellsundergoing a common functional process.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Naive CD8 T cell.L2,Level 2 cell type,#63A686,"Naive CD8 T cell: Naive CD8 T cells are an antigen-inexperienced alpha-beta-expressing CD8 T cell population. This population is defined by expression ofCD27,CCR7,SELL,TCF7andLEF1, and the lack of granzyme genesGZMA,GZMK,orGZMB, as well as a lack ofITGB1, an integrin specifically expressed on memory T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Memory CD8 T cell.L2,Level 2 cell type,#314937,"Memory CD8 T cell: Memory CD8 T cells arise when Naive CD8 T cells encounter their cognate antigen and receive further activating signals thatsupport differentiation. This population isdelineated in scRNA-seq by the expression ofITGB1, high expression of granzyme genesGZMA,GZMB, orGZMK, and reduced or no expression ofCCR7in conjunction withTRAC(TCR alpha subunit) expression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD8aa.L2,Level 2 cell type,#7ECDAD,"CD8aa: CD8 alpha-alpha (CD8aa) T cells are a recently-described subset of alpha-beta T cells with effector-like properties (Thomson,et al., 2023; Terekhova,et al., 2023). These cells are defined by expression of highCD8A,KLRC2,IKZF2, andIL21R, andisclosely associated with certain gdT cell subsets. (Thomson,et al., 2023)",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gdT.L2,Level 2 cell type,#72AF5A,gdT: Gamma-delta T cells (gdT) are a subset of T cells that express a T cell receptor (TCR)composed of gamma and delta subunits instead of alpha and beta subunits. This population is delineated from alpha-beta T cells by high expression ofTRDC(TCR delta subunit) as well asTRGC1andTRGC2(TCR gamma subunits) in the absence ofTRAC(TCR alpha subunit) expression. gdT cells are classically known for the ability to recognize soluble proteins and endogenous non-protein antigens.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAIT.L2,Level 2 cell type,#1E8F64,MAIT: Mucosal-associated invariant T (MAIT) cells are a subset of alpha-beta T cells with a semi-invariant TCR andinnate-like features. This population is defined by the expression of themarker geneSLC4A10and high expression ofKLRB1(i.e. CD161).,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Transitional B cell.L2,Level 2 cell type,#9C6469,"Transitional B cell: Transitional or immature B cells are the population that first emerge into circulation after B cell development in the bone marrow. These cells can be distinguished from other subsets by higherMME,CD9,CD38,PAX5, andFCER2expression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Naive B cell.L2,Level 2 cell type,#D5ABAB,"Naive B cell: Naive B cells are a more developed population than Transitional B cells. Their primary function is to circulate through blood and lymph between various lymphoid tissues in search of the cognate antigen of their unique BCR. This population expresses theIL4RandFCER2genes similar to Transitional B cells, but have lower expression ofMME,CD24, andCD9.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Memory B cell.L2,Level 2 cell type,#B16B72,"Memory B cell: Memory B cells arise when Naive B cells encounter their cognate antigen and receive further activating signals, which support differentiation and affinity maturation (King,et al., 2021; Phad,et al., 2022; Glass,et al., 2020). This population isdefined byCD27andAIM2gene expression. Memory cell populations also have higher expression of IgH constant region genes that specify class-switched isotype, includingIGHG1,IGHG2,IGHG3,IGHG4,IGHA1,IGHA2, andIGHE.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Effector B cell.L2,Level 2 cell type,#F4CEC3,"Effector B cell: In this atlas, Effector B cells are a type of memory B cell with a distinct phenotype, defined by greater gene expression ofITGAX,FCRL4,FCRL5,TBX21,ZEB2, andPDCD1. These cells present a wide spectrum ofCD27andAIM2expression, including non-expression. This memory population has been historically captured under a variety of names, including atypical B cells, CD27-IgD-or DN2 cells, CD21lowB cells, FCRL4/5+ cells, Tbet+B cells, CD11c+CD19hiEffector B cells, and activated or age-associated memory B cells. The origins and function of this rare and distinctive memory population remains yet to be clearly elucidated in humans (Gao and Cockburn 2022). These cells arise in an antigen-responsive manner and are a component of the antigen-specific B cell population in the context of COVID and influenza vaccination (Sutton,et al., 2021; Glass,et al., 2020; Ellebedyet al., 2016; Priestet al., 2024). This population is also highly expanded in individuals with certain autoimmune conditions and those that have experienced multiple Malaria infections (Jenks,et al., 2018; Suttonet al., 2021).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Plasma cell.L2,Level 2 cell type,#784D47,"Plasma cell: This antibody-producing population is clearly distinguishable from the rest of the B cell compartment due to a large number of unique transcriptional features (Nutt et al. 2015; Phad et al. 2022; King et al. 2021). As mentioned earlier, this subset lacks expression ofMS4A1(also known as CD20)andPAX5, which are ubiquitously expressed by all other B cell populations. However, these cellssustain expression of another B cell lineage-defining receptor gene,CD19, when in the absence of immune perturbationssuch as vaccination or infections. Plasma cells also express subset-defining transcription factor and regulatory protein genes, namelyPRDM1,XBP1,MZB1, andSLAMF7. Finally, these cells have especially high expression of theCD27andCD38genes as well as most of the BCR heavy chain constant region genes, excepting for lessIGHDtranscript.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD56bright NK cell.L2,Level 2 cell type,#FF7F55,CD56bright NK cell: CD56brightCD16lowclusters were assigned the CD56bright NK cell label based on highNCAM1and lowFCGR3Aexpression.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD56dim NK cell.L2,Level 2 cell type,#E16040,"CD56dim NK cell: CD56dimCD16hiclusters were assigned the CD56dim NK cell label based on low expression of the neural cell adhesion molecule 1 (NCAM1) gene and high expression of the Fc gamma receptor IIIa (FCGR3A) gene, which encode CD56 and CD16, respectively.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Proliferating NK cell.L2,Level 2 cell type,#CC3B18,Proliferating NK cell: Proliferating NK cells were identified as clusters with high expression of the marker of proliferation Ki-67 (MKI67) gene.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD14 monocyte.L2,Level 2 cell type,#F6831B,"CD14 monocyte: CD14 monocyte is the most abundant monocyte subset. CD14 monocytes are distinguished from the other Level 2 monocyte cell types by higher expression of theCD14gene, versican (VCAN), and S100 calcium binding proteins A8 and A9 (S100A8andS100A9). CD14 monocytes had lower expression of the Fc gamma receptor IIIa gene (FCGR3A) than CD16 monocytes, and lower major histocompatibility complex, class II, DR alpha (HLA-DRA) expression than Intermediate monocytes.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Intermediate monocyte.L2,Level 2 cell type,#B75228,"Intermediate monocyte: Intermediate monocytes areidentified based on their double-positive surface expression of CD14 and CD16. In addition to coexpression of the correspondingCD14andFCGR3Agenes, Intermediate monocytes have higher expression of major histocompatibility complex, class II genes includingHLA-DAP1,HLA-DOA,HLA-DRA, andCD74compared to CD14 and CD16 monocyte types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD16 monocyte.L2,Level 2 cell type,#FCAF87,"CD16 monocyte: CD16 monocytes are distinguished by high expression of the gene encoding the CD16 surface marker (FCGR3A), as well as cyclin dependent kinase inhibitor 1C (CDKN1C), and leukocyte specific transcript 1 (LST1). ",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cDC2.L2,Level 2 cell type,#BE6E23,"cDC2: Conventional type 2 dendritic cells (cDC2) are the largest DC subset, and have high expression of the CD1c molecule gene (CD1C), and share expression of the ficolin 1 (FCN1) gene and paired immunoglobin like type 2 receptor alpha (PILRA) gene with monocyte cell types, but not other DC types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cDC1.L2,Level 2 cell type,#F8C755,"cDC1: Conventional type 1 dendritic cells (cDC1) were identified as DCs with high expression of the CD370 geneC-type lectin domain containing 9A (CLEC9A), X-C motif chemokine receptor 1 (XCR1), indoleamine 2,3-dioxygenase 1 (IDO1), and theC1orf54gene.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pDC.L2,Level 2 cell type,#FBB64E,"pDC: Plasmacytoid dendritic cells express pre-T cell antigen receptor alpha (PTCRA), and small integral membrane protein 5 (SMIM5), which are also expressed in platelets. pDCs also express the lysosomal associated membrane protein family member 5 (LAMP5) gene, as well as of the CD123 gene interleukin 3 receptor subunit alpha (IL3RA) and the joining chain of multimeric IgA and IgM (JCHAIN) gene, both of which are also expressed inASDCs and some B cell types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASDC.L2,Level 2 cell type,#8A4E1C,"ASDC: AXL+ SIGLEC6+ dendritic cells (ASDCs) were identified as DCs that express a distinct transcriptome profile including genes for AXL receptor tyrosine kinase (AXL), the CD327 genesialic acid binding Ig like lectin 6 (SIGLEC6), as well as hepcidin antimicrobial peptide (HAMP).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ILC.L2,Level 2 cell type,#F4AD3A,"ILC: We identify a population at all levels of our type hierarchy for ILCs. While further division of subpopulations of ILCs is possible (Spits and Cupedo, 2012), the low abundance of circulating ILCs available in our PBMC dataset prevented further segregation of subclasses.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Progenitor cell.L2,Level 2 cell type,#A31001,"Progenitor cell: Progenitor cells are rare in peripheral blood, and this class encapsulates three diverse progenitor cell types found in blood, which are described in more detail at Level 3. Progenitor cells can be identified by expression of the small integral membrane protein 24 gene (SMIM24) or the CD34 molecule gene (CD34).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Platelet.L2,Level 2 cell type,#5B3930,Platelet: Platelets are blood clotting components derived from the cytoplasm of megakaryocytes and lack a nucleus. They can be identified by high levels of the pro-platelet basic protein gene (PPBP) and the tubulin beta 1 class VI gene (TUBB1).,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Erythrocyte.L2,Level 2 cell type,#1F1515,"Erythrocyte: Erythrocytes, often referred to as red blood cells, are cells that carry hemoglobin throughout the body. These cells can be identified by expression of the hemoglobin alpha 1 and 2 gene or the hemoglobin beta gene (HBA1,HBA2, andHBB, respectively). Erythrocytes also lack a nucleus, so have fewer detected genes per cell than most other cell types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SOX4+ naive CD4 T cell.L3,Level 3 cell type,#2B5777,"SOX4+ naive CD4 T cell: This Naive CD4 T cell population is delineated from Core Naive CD4 T cell by a bias towards animmature T cell gene expression profile, in particularSOX4.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Core naive CD4 T cell.L3,Level 3 cell type,#597FC6,"Core naive CD4 T cell: Core naive CD4 T cells are the major antigen-inexperienced CD4 T cell population. This population is defined by expression ofCD27,CCR7,SELL,TCF7andLEF1, and the lack ofITGB1, an integrin specifically expressed on memory T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ naive CD4 T cell.L3,Level 3 cell type,#072E77,"ISG+ naive CD4 T cell: This Naive CD4 T cell population is delineated from Core Naive CD4 T cell by theexpression of type-I interferon signaling genes (ISG), such asMX1andIFI44.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CM CD4 T cell.L3,Level 3 cell type,#6793A4,"CM CD4 T cell: Central memory (CM) CD4 T cells are a memory T subset defined byhigh expression ofCCR7,SELL, andLEF1compared with other memory CD4 T cell populations.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMB- CD27+ EM CD4 T cell.L3,Level 3 cell type,#406B9C,"GZMB- CD27+ EM CD4 T cell: This memory CD4 T cell population is defined by expression ofCD27andGZMKin the absence ofGZMBexpression and lowCCR7,SELL, andLEF1expression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMB- CD27- EM CD4 T cell.L3,Level 3 cell type,#233C5B,"GZMB- CD27- EM CD4 T cell: This memory CD4 T cell population is defined by low expression ofCCR7,SELL, andLEF1, as well as lowGZMAand noGZMKorGZMBexpression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ memory CD4 T cell.L3,Level 3 cell type,#5480A3,"ISG+ memory CD4 T cell: This memory CD4 T cell population is delineated from other memory CD4 T cells by theexpression of type-I interferon signaling genes (ISG), such asMX1andIFI44.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRF1- GZMB+ CD27- memory CD4 T cell.L3,Level 3 cell type,#628088,"KLRF1- GZMB+ CD27- memory CD4 T cell: This memory CD4 T cell population is defined by high expression ofGZMBandCCL5with noKLRF1,CD27, orGZMKexpression. This subset is closely associated with GZMB+ CD27- EM CD8 T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Naive CD4 Treg.L3,Level 3 cell type,#8EB5D7,"Naive CD4 Treg: Naive CD4 regulatory T cells (Treg) are an antigen-inexperienced CD4 Treg population. This population is defined by expression Treg markers with additional expression ofCD27,CCR7,SELL,TCF7, andLEF1, and the lack ofITGB1, an integrin specifically expressed on memory T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Memory CD4 Treg.L3,Level 3 cell type,#001A9A,"Memory CD4 Treg: Memory CD4 regulatory T cells (Treg) arise when Naive CD4 Tregs encounter their cognate antigen and receive further activating signals, which support differentiation. This population isdelineated in scRNA-seq by the expression ofITGB1.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRB1+ memory CD4 Treg.L3,Level 3 cell type,#3B76C1,KLRB1+ memory CD4 Treg: This memory CD4 Treg population is delineated from Memory CD4 Tregs by a more innate-like gene expression profile includingKLRB1but notGZMK.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMK+ memory CD4 Treg.L3,Level 3 cell type,#A3B7C2,GZMK+ memory CD4 Treg: This memory CD4 Treg population is delineated from Memory CD4 Tregs by theexpression ofGZMKbut notKLRB1.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Memory CD8 Treg.L3,Level 3 cell type,#C3D1DA,Memory CD8 Treg: This memory Treg population is delineated from Memory CD4 Tregs by the expression ofCD8Aand notCD4.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRB1+ memory CD8 Treg.L3,Level 3 cell type,#C7E0C6,KLRB1+ memory CD8 Treg: This memory CD8 Treg population is delineated from Memory CD8 Tregs by theexpression ofKLRB1.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DN T cell.L3,Level 3 cell type,#656E68,"DN T cell: Double-negative (DN) T cells are defined as alpha-beta T cell populations (expressingTRAC) that lack the expression ofCD4,CD8AandCD8B.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Proliferating T cell.L3,Level 3 cell type,#AEAEB0,"Proliferating T cell: Proliferating T cells are defined as alpha-beta or gamma-delta T cell populations that express genes indicative of cell cycling, includingMKI67. This is a mixed population of T cellsundergoing a common functional process.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SOX4+ naive CD8 T cell.L3,Level 3 cell type,#465F32,"SOX4+ naive CD8 T cell: This Naive CD8 T cell population is delineated from Core Naive CD8 T cell via its more immature T cell gene expression profile, in particularSOX4expression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Core naive CD8 T cell.L3,Level 3 cell type,#63A686,"Core naive CD8 T cell: Core naive CD8 T cells are the major antigen-inexperienced CD8 T cell population. This population is defined by expression ofCD27,CCR7,SELL,TCF7andLEF1, and the lack ofITGB1, an integrin specifically expressed on memory T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ naive CD8 T cell.L3,Level 3 cell type,#869A94,"ISG+ naive CD8 T cell: This Naive CD8 T cell population is delineated from Core Naive CD8 T cell via its expression of type-I interferon signaling genes (ISG), such asMX1andIFI44.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CM CD8 T cell.L3,Level 3 cell type,#6D9F5E,"CM CD8 T cell: Central memory (CM) CD8 T cells are defined by their higher expression ofCCR7,SELLandLEF1compared with other memory CD8 T cell populations.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMK+ CD27+ EM CD8 T cell.L3,Level 3 cell type,#95BDA1,"GZMK+ CD27+ EM CD8 T cell: This memory CD8 T cell population is defined by high expression ofCD27andGZMKin the absence ofGZMBexpression and lowCCR7,SELL, andLEF1expression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRF1- GZMB+ CD27- EM CD8 T cell.L3,Level 3 cell type,#59895F,"KLRF1- GZMB+ CD27- EM CD8 T cell: This memory CD4 T cell population is defined by high expression ofGZMBandCCL5with noKLRF1,CD27, orGZMKexpression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMK- CD27+ EM CD8 T cell.L3,Level 3 cell type,#314937,"GZMK- CD27+ EM CD8 T cell: This memory CD8 T cell population is defined by high expression ofCD27, low expression ofCCR7,SELL, andLEF1and no expression ofGZMKorGZMB.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRF1+ GZMB+ CD27- EM CD8 T cell.L3,Level 3 cell type,#4E695B,"KLRF1+ GZMB+ CD27- EM CD8 T cell: This memory CD8 T cell population is defined by high expression ofKLRF1,GZMB,andCCL5with noCD27orGZMKexpression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ memory CD8 T cell.L3,Level 3 cell type,#94C0AD,"ISG+ memory CD8 T cell: This memory CD8 T cell population is delineated from other memory CD8 T cells via its expression of type-I interferon signaling genes (ISG), such asMX1andIFI44.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD8aa.L3,Level 3 cell type,#7ECDAD,"CD8aa: CD8 alpha-alpha (CD8aa) T cells are a recently-described subset of alpha-beta T cells with effector-like properties (Thomson,et al., 2023; Terekhova,et al., 2023). These cells are defined by expression of highCD8A,KLRC2,IKZF2, andIL21R, andisclosely associated with certain gdT cell subsets. (Thomson,et al., 2023)",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SOX4+ Vd1 gdT.L3,Level 3 cell type,#B6D7C8,"SOX4+ Vd1 gdT: This Naive-like gdT cell population is delineated from Naive Vd1 gdT cells by an immature T cell gene expression profile, in particularSOX4expression.This subset is also transcriptionally similar to CD8aa T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Naive Vd1 gdT.L3,Level 3 cell type,#537E41,"Naive Vd1 gdT: This gdT cell subset is delineated by high expression ofCCR7,SELL, andLEF1with lowITGB1expression. This subset is transcriptionally similar to CD8aa T cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRF1- effector Vd1 gdT.L3,Level 3 cell type,#A39E78,"KLRF1- effector Vd1 gdT: This gdT cell subset is defined byexpression ofTRDC,TRDV1and the lack ofKLRF1expression. This subset is transcriptionally similar to GZMB+ effector memory CD8 and CD4 T cell subsets.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KLRF1+ effector Vd1 gdT.L3,Level 3 cell type,#7CB38E,"KLRF1+ effector Vd1 gdT: This gdT cell subset is defined byexpression ofTRDC,TRDV1, andKLRF1. This subset is transcriptionally similar to GZMB+ CD8 and CD4 T cell subsets.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMK+ Vd2 gdT.L3,Level 3 cell type,#72AF5A,"GZMK+ Vd2 gdT: ThisgdT cell subset is defined by their expression ofTRDC,TRDV2, andGZMK. This subset is transcriptionally similar to MAIT cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMB+ Vd2 gdT.L3,Level 3 cell type,#AECFB1,"GZMB+ Vd2 gdT: ThisgdT cell subset is defined by their expression ofTRDC,TRDV2, andGZMB. This subset is transcriptionally similar to MAIT cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD8 MAIT.L3,Level 3 cell type,#1E8F64,"CD8 MAIT: CD8 MAIT cells, the main population of MAIT cells in the blood, are delineated from CD4 MAIT cells byexpression ofCD8A.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD4 MAIT.L3,Level 3 cell type,#6F723F,CD4 MAIT: CD4 MAIT cells are delineated from CD8 MAIT cells by expression ofCD4.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ MAIT.L3,Level 3 cell type,#BBB788,"ISG+ MAIT: This MAIT cell population is delineated from L2 MAIT cells via its expression of type-I interferon signaling genes, such asMX1andIFI44.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Transitional B cell.L3,Level 3 cell type,#9C6469,"Transitional B cell: Transitional or immature B cells are the population that first emerge into circulation after B cell development in the bone marrow. These cells can be distinguished from other subsets by higherMME,CD9,CD38,PAX5, andFCER2expression.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Core naive B cell.L3,Level 3 cell type,#D5ABAB,Core naive B cell: The same gene expression profile described for level 2 Naive B cells applies for this level 3 label. This population is the most abundant B cell subset in the periphery.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ naive B cell.L3,Level 3 cell type,#D9A996,"ISG+ naive B cell: This small naive B cell subset is defined by a unique profile of interferon response-related gene expression. In this atlas, population-defining genes includeSTAT3,STAT1,IFI44L, andISG15.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Early memory B cell.L3,Level 3 cell type,#362027,"Early memory B cell: The Early Memory B cell subset represents a transitional population between antigen-inexperienced and antigen-experienced B cells. Prior studies of this populations surface phenotype and IgH complementarity-determining region 3 (CDR3) indicate that these are antigen-exposed cells with intermediate memory phenotypes and CDR3 somatic mutational burdens (Glass,et al., 2020). Here, we define this population by intermediate expression of memory-defining genes,CD27,AIM2and class-switched isotype IgH (IGHA1,IGHA2andIGHG1,IGHG2,IGHG3, andIGHG4). Intermediate is defined as being between level 2 Naive and Memory B cell median expression levels. It should be noted that this transcription-based labeling approach is less accurate than utilizing a surface marker-based approach, defined by the presence ofCD45RBin a specific glycosylated form that can be detected with the MEM55 antibody clone (Koers,et al., 2022).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Core memory B cell.L3,Level 3 cell type,#B16B72,Core memory B cell: This population represents the largest portion of the peripheral memory B cell compartment. The gene expression profile described for level 2 Memory B cells applies to this level 3 label without further gene expression requirements.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Activated memory B cell.L3,Level 3 cell type,#60545A,"Activated memory B cell: This small memory B cell subset is defined by a unique profile of activation-related gene expression, includingFOS,CD69,JUN,MCL1, andMYC. The detection and abundance of this population among healthy individuals varies greatly, and is likely a reflection that this label captures a distinguishable memory cell state rather than a stable, functional subset.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Type 2 polarized memory B cell.L3,Level 3 cell type,#4E2927,"Type 2 polarized memory B cell: In our atlas, we capture a recently defined, type 2 immunity-polarized memory population that is enriched for allergen-specific cells as well as IgE+ plasma cell precursors (Ota,et al., 2024; Koenig,et al., 2024) . These memory cells are distinguishable by expression ofIL4R,FCER2,COCH,IGHG1,IGHG4, andIGHE.IGHEgene expression by memory B cells represents mostly germline transcription, given that it is primarily plasma cells that express functional IgE+ BCR or antibodies.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD95 memory B cell.L3,Level 3 cell type,#EBC3A7,"CD95 memory B cell: CD95+ memory B cells are defined by high expression of theFASgene, which encodes theCD95protein, also calledFas cell surface death receptor(Glass,et al., 2020). This population also displays the highestAIM2and class-switched isotype IgH (IGHA1,IGHA2,IGHG1,IGHG2,IGHG3, andIGHG4) gene expression among memory B cell subsets. The origins and functions of this memory subset in humans are not entirely clear, although it has been suggested that these cells could be recent germinal center emigrants.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD27+ effector B cell.L3,Level 3 cell type,#F4CEC3,CD27+ effector B cell: This subset of Effector memory B cells is distinguished by positive expression ofCD27and tends to have more transcriptional overlap with other memory B cells than the CD27- population.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD27- effector B cell.L3,Level 3 cell type,#A3787B,"CD27- effector B cell: This subset of Effector memory B cells is distinguished by a lack ofCD27expression. These cells also tend to have lower expression ofAIM2and higher expression of some subset-defining genes, such asITGAX,TBX21, andZEB2.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Plasma cell.L3,Level 3 cell type,#784D47,"Plasma cell: This antibody-producing population is clearly distinguishable from the rest of the B cell compartment due to a large number of unique transcriptional features (Nutt et al. 2015; Phad et al. 2022; King et al. 2021). As mentioned earlier, this subset lacks expression ofMS4A1(also known as CD20)andPAX5, which are ubiquitously expressed by all other B cell populations. However, these cellssustain expression of another B cell lineage-defining receptor gene,CD19, when in the absence of immune perturbationssuch as vaccination or infections. Plasma cells also express subset-defining transcription factor and regulatory protein genes, namelyPRDM1,XBP1,MZB1, andSLAMF7. Finally, these cells have especially high expression of theCD27andCD38genes as well as most of the BCR heavy chain constant region genes, excepting for lessIGHDtranscript.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD56bright NK cell.L3,Level 3 cell type,#FF7F55,CD56bright NK cell: CD56brightCD16lowclusters were assigned the CD56bright NK cell label based on highNCAM1and lowFCGR3Aexpression.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMK+ CD56dim NK cell.L3,Level 3 cell type,#A31001,GZMK+ CD56dim NK cell: Cell clusters expressing the granzyme K (GZMK) gene were assigned the label GZMK+ CD56dim NK cell.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GZMK- CD56dim NK cell.L3,Level 3 cell type,#E16040,GZMK- CD56dim NK cell: Remaining CD56dim NK cells that did not express the markers above formed a uniform group of cells that were assigned the GZMK- CD56dim NK cell label.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Adaptive NK cell.L3,Level 3 cell type,#781B15,"Adaptive NK cell: CD16-positive clusters that also expressed high levels of killer cell lectin like receptor C2 (KLRC2) transcription were assigned the Adaptive NK cell label. Adaptive NK cells have been described as a type that expands in response to CMV infection in mice (Sun, et al. 2009) and humans (Lopz-Verges, et al. 2011).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ CD56dim NK cell.L3,Level 3 cell type,#EEA172,"ISG+ CD56dim NK cell: Clusters with high expression of interferon-stimulated genes (ISG), including ISG15 ubiquitin like modifier (ISG15), and MX dynamin like GTPase 1 and 2 (MX1, andMX2, respectively)were assigned the ISG+ CD56dim NK cell label.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Proliferating NK cell.L3,Level 3 cell type,#CC3B18,,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Core CD14 monocyte.L3,Level 3 cell type,#F6831B,Core CD14 monocyte: The remaining CD14 monocytes that did not express the distinct transcriptome signatures for IL1B+ or ISG+ CD14 monocytes were assigned the Core CD14 monocyte label.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ CD14 monocyte.L3,Level 3 cell type,#DE5A07,"ISG+ CD14 monocyte: Similar to many other key immune subsets in our atlas, a subset of CD14 monocytes display a strong interferon-stimulated gene (ISG) transcriptome signature. These cells express high levels of ISGs including MX dynamin like GTPase 1 (MX1), interferon induced protein 44 like (IFI44L), and interferon alpha inducible protein 6 (IFI6). A recent report also identified this population in human PBMCs and shows it is a stable monocyte subset that not only exists in healthy subjects, but also in cancer patients (Affandi, et al. 2021).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
IL1B+ CD14 monocyte.L3,Level 3 cell type,#BE4C26,"IL1B+ CD14 monocyte: IL1B+ CD14 monocytes are a relatively rare subset of CD14 monocytes that have been recently shown to expand in the blood of checkpoint blockade-induced inflammatory arthritis patients (Zhou, et al. 2024). In addition to possessingCD14 monocyte transcriptome signatures, IL1B+ CD14 monocytes express high levels of the interleukin 1 beta gene (IL1B), the C-C motif chemokine ligand 3 gene (CCL3), and the C-X-C motif chemokine ligand 8 gene (CXCL8).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Intermediate monocyte.L3,Level 3 cell type,#B75228,,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Core CD16 monocyte.L3,Level 3 cell type,#FCAF87,Core CD16 monocyte: The remaining CD16 monocytes that did not express the distinct transcriptomic signatures for C1Q+ or ISG+ CD16 monocytes were assigned the Core CD16 monocyte label.,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ CD16 monocyte.L3,Level 3 cell type,#DB6A2E,"ISG+ CD16 monocyte: As described for CD14 monocytesabove, we identify an analogous ISG+ cell type among CD16 monocytes that express ISGs includingMX1,IFI44L, andIFI6.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C1Q+ CD16 monocyte.L3,Level 3 cell type,#F4BA81,"C1Q+ CD16 monocyte: C1Q+ CD16 monocytes are a cell type that has been recently reported in subjects with Behets disease, and may mediate hyperinflammation in this setting (Zheng, et al. 2022). However, we also identify these cells as a small subset of CD16 monocytes in our healthy cohorts across age. These monocytes are distinguished by high expression of the complement C1q A chain and B chain genes (C1QAandC1QB, respectively)",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CD14+ cDC2.L3,Level 3 cell type,#FEDC7A,"CD14+ cDC2: As previously reported (Villani, et al. 2017; Duterte, et al. 2019), we identified a subset of cDC2 that is transcriptomically similar to CD14 monocytes, which we call CD14+ cDC2. These cDC2 cells coexpressed cDC2 marker genes, such asCST3,CD74,HLA-DRA, andHLA-DPA1, as well as CD14 monocyte-related genes such asCD14, S100 calcium binding protein A8 and A9 (S100A8andS100A9), versican (VCAN), and the CD163 molecule gene (CD163).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLA-DRhi cDC2.L3,Level 3 cell type,#BE6E23,"HLA-DRhi cDC2: A subset of cDC2 expressed lower levels of CD14 monocyte-related markers than the CD14+ cDC2 subset, and the highest level of major histocompatibility complex, class II genes, such asHLA-DPA1,HLA-DRA, andCD1Camong cDC2 cell types. Due to their high MHC class II-related expression, we assigned these cells the HLA-DRhi cDC2 label.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ISG+ cDC2.L3,Level 3 cell type,#8C6527,"ISG+ cDC2: A subset of cDC2 cells displayed a strong interferon-stimulated gene (ISG) transcriptome signature, including ISGs such as MX dynamin like GTPase 1 (MX1), interferon induced protein 44 like (IFI44L), and interferon alpha inducible protein 6 (IFI6). These cDCs were assigned the ISG+ cDC2 label.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cDC1.L3,Level 3 cell type,#F8C755,"cDC1: Conventional type 1 dendritic cells (cDC1) were identified as DCs with high expression of the CD370 geneC-type lectin domain containing 9A (CLEC9A), X-C motif chemokine receptor 1 (XCR1), indoleamine 2,3-dioxygenase 1 (IDO1), and theC1orf54gene.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pDC.L3,Level 3 cell type,#FBB64E,"pDC: Plasmacytoid dendritic cells express pre-T cell antigen receptor alpha (PTCRA), and small integral membrane protein 5 (SMIM5), which are also expressed in platelets. pDCs also express the lysosomal associated membrane protein family member 5 (LAMP5) gene, as well as of the CD123 gene interleukin 3 receptor subunit alpha (IL3RA) and the joining chain of multimeric IgA and IgM (JCHAIN) gene, both of which are also expressed inASDCs and some B cell types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASDC.L3,Level 3 cell type,#8A4E1C,"ASDC: AXL+ SIGLEC6+ dendritic cells (ASDCs) were identified as DCs that express a distinct transcriptome profile including genes for AXL receptor tyrosine kinase (AXL), the CD327 genesialic acid binding Ig like lectin 6 (SIGLEC6), as well as hepcidin antimicrobial peptide (HAMP).",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ILC.L3,Level 3 cell type,#F4AD3A,"ILC: We identify a population at all levels of our type hierarchy for ILCs. While further division of subpopulations of ILCs is possible (Spits and Cupedo, 2012), the low abundance of circulating ILCs available in our PBMC dataset prevented further segregation of subclasses.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLP cell.L3,Level 3 cell type,#FCDB97,"CLP cell: Common lymphoid progenitor (CLP) cells give rise to lymphoid cell types including T, B, and NK cells.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMP cell.L3,Level 3 cell type,#5B3006,"CMP cell:Common myeloid progenitor (CMP) cells produce megakaryocytes and precursors to erythrocytes, monocytes, and granulocytes.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BaEoMaP cell.L3,Level 3 cell type,#3D1F15,"BaEoMaP cell: Basophil, eosinophil, mast progenitor (BaEoMaP) cells are precursors derived from CMP cells that specialize in development of these granulocyte populations.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Platelet.L3,Level 3 cell type,#5B3930,Platelet: Platelets are blood clotting components derived from the cytoplasm of megakaryocytes and lack a nucleus. They can be identified by high levels of the pro-platelet basic protein gene (PPBP) and the tubulin beta 1 class VI gene (TUBB1).,Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Erythrocyte.L3,Level 3 cell type,#1F1515,"Erythrocyte: Erythrocytes, often referred to as red blood cells, are cells that carry hemoglobin throughout the body. These cells can be identified by expression of the hemoglobin alpha 1 and 2 gene or the hemoglobin beta gene (HBA1,HBA2, andHBB, respectively). Erythrocytes also lack a nucleus, so have fewer detected genes per cell than most other cell types.",Additional information available at:,https://apps.allenimmunology.org/aifi/resources/imm-health-atlas/cell-type-descriptions/,Please disregard any other rows that show up below this point.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
